API
< Back to situations

[ORGANIZATION]

Fondazione Policlinico Universitario A. Gemelli IRCCS

Featured in 6 tracked stories · first seen

Situations

[ACTIVE] [HEALTH] [IT]

AIFA rare disease treatment approvals in Italy

2 clusters · 24 sources · last updated

Latest: Italy approves reimbursement for mirdametinib to treat neurofibromatosis type 1

The Italian Medicines Agency (AIFA) has expanded the reimbursement of several specialized therapies through the National Health Service. On October 29, 2026, AIFA approved reimbursement for beremagene geperpavec (Vyjuv

[QUIET] [HEALTH] [US] [ES] [AT]

Alzheimer's research: Detection, trials, and efficacy debate

27 clusters · 97 sources · last updated

Latest: Alzheimer’s research advances with new therapies and ultrasound trials

Research into Alzheimer’s disease continues to evolve, focusing on early detection, molecular mapping, and the physiological breadth of the condition. While previous efforts emphasized biomarkers and AI-driven diagnostic

[QUIET] [HEALTH] [US] [IN] [IT]

CKD management, diagnostic gaps, and research updates

7 clusters · 40 sources · last updated

Latest: Kidney disease research highlights diagnostic gaps and regional disparities

Chronic kidney disease (CKD) remains a significant global health issue, affecting an estimated 850 million people. Because the kidneys lack pain-sensing nerves, many patients remain unaware of their condition until signi